BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10216133)

  • 1. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
    Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
    Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
    Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
    Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.
    Greupink R; Bakker HI; Bouma W; Reker-Smit C; Meijer DK; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2006 May; 317(2):514-21. PubMed ID: 16439617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
    Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
    J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
    J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
    Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
    Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
    van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
    J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
    Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
    Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
    Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
    Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.
    Li FQ; Su H; Chen X; Qin XJ; Liu JY; Zhu QG; Hu JH
    J Pharm Pharmacol; 2009 Sep; 61(9):1155-61. PubMed ID: 19703364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
    Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
    Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine.
    Rachmawati H; Reker-Smit C; Lub-de Hooge MN; van Loenen-Weemaes A; Poelstra K; Beljaars L
    Drug Metab Dispos; 2007 May; 35(5):814-21. PubMed ID: 17312017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.
    Greupink R; Bakker HI; Reker-Smit C; van Loenen-Weemaes AM; Kok RJ; Meijer DK; Beljaars L; Poelstra K
    J Hepatol; 2005 Nov; 43(5):884-92. PubMed ID: 16083988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-induced drug targeting using novel peptide-ligand albumins.
    Meijer DK; Beljaars L; Molema G; Poelstra K
    J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated rats.
    Greupink R; Reker-Smit C; Proost JH; van Loenen Weemaes AM; de Hooge M; Poelstra K; Beljaars L
    Biochem Pharmacol; 2007 May; 73(9):1455-62. PubMed ID: 17239825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Patel G; Kher G; Misra A
    J Drug Target; 2012 Feb; 20(2):155-65. PubMed ID: 21913877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeting glycyrrhetinic acid to hepatic stellate cells in treating rat liver fibrosis].
    Zhang QS; Luk JM; Zhang J; Tian GY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):664-7. PubMed ID: 16174454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of a triplex-forming oligonucleotide to hepatic stellate cells.
    Ye Z; Cheng K; Guntaka RV; Mahato RI
    Biochemistry; 2005 Mar; 44(11):4466-76. PubMed ID: 15766277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
    Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
    Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.